Scientific Program – Fetomaternal MedicineSaturday, November 23, 2024 |
08:30-09:00 | GOOD MORNING LISBON PLENARY LECTURE | HALL A |
09:00-10:30 | PRENATAL DIAGNOSIS AND GENETICS | HALL D |
Chairpersons | Asma Khalil, UK Alvaro Cohen, Portugal |
|
09:00-09:20
09:00-09:05 |
Debate: Should we perform array-based comparative genomic hybridization for all
Yes: Amir Aviram, Canada |
|
09:20-09:40
09:20-09:25 |
Debate: Should we perform whole exome sequencing for all?
Yes: Amir Aviram, Canada |
|
09:40-09:55 | What is the value of genetic testing in small babies Asma Khalil, UK |
|
09:55-10:10 | What are the true numbers of amniocentesis-related and chorionic-villus-sampling-related fetal losses? Eyal Sheiner, Israel |
|
10:10-10:30 | Third trimester scan is not just a growth scan Asma Khalil, UK |
10:30-11:00 | Coffee break, visit the exhibition, and e-poster viewing |
11:00-12:30 | OBESITY AND GESTATIONAL DIABETES MELLITUS (GDM) | HALL D |
Chairpersons |
Gerard Visser, Netherlands |
|
11:00-11:20
11:00-11:05 |
Debate: Should we screen and treat GDM prior to 24 weeks of gestation? Yes: Gerard Visser, Netherlands |
|
11:20-11:40
11:20-11:25 |
Debate: Should we counsel overweight/obese patients to lose weight during pregnancy? Yes: Gerard Visser, Netherlands |
|
11:40-11:50 |
What is a well-controlled patient in GDM? |
|
11:50-12:10
11:50-11:55 |
Debate: Should we induce all diabetic patients at 38 weeks of gestation? Yes: Yariv Yogev, Israel |
|
12:10-12:25 | Extreme obesity (BMI>50) Dan Farine, Canada |
|
12:25-12:30 |
Discussion |
12:30-13:30 | Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions |
13:30-15:00 | NEW ASPECTS IN FETAL MEDICINE | HALL D |
Chairpersons | Asma Khalil, UK Susana Santo, Portugal |
|
13:30-13:50 |
Is there a role for fetal surgery in neural tube defects? – A debate |
|
13:50-14:15 |
In utero gene therapy – a new horizon? |
|
14:15-14:35 |
Long-term outcomes of fetal growth restriction |
|
14:35-14:55 |
New developments in the area of non-invasive prenatal testing from fetal DNA in maternal blood |
|
14:55-15:00 |
Discussion |
15:00-16:30 | FETAL GROWTH RESTRICTION (FGR) AND PRE-ECLAMPSIA | HALL D |
Chairpersons |
Asma Khalil, UK |
|
15:00-15:20 15:00-15:05 |
Debate: We can screen for pre-eclampsia but is treatment efficient? Yes: Luisa Pinto, Portugal |
|
15:20-15:35 |
When to recommend delivery in late-onset FGR? |
|
15:35-15:55 15:35-15:40 |
Debate: Breaking growth curve during pregnancy not reaching the 10th percentile- A concern? Yes: Nir Melamed, Canada |
|
15:55-16:30 |
What is the best strategy to prevent recurrent pre-eclampsia- aspirin, low-molecular-weight heparin, statins, progesterone, combination of these? Moderators: Panel Discussion: |